Trial Profile
Effects of tetrahydrobiopterin (6R-BH4) on flow-mediated dilation in CADASIL patients: a randomised controlled trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Sapropterin (Primary)
- Indications CADASIL
- Focus Adverse reactions; Therapeutic Use
- Acronyms CADASIL-BH4
- 24 Nov 2015 New trial record